U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
ABELACIMAB
INN  
Official Name English
Abelacimab [WHO-DD]
Preferred Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN BLOOD-COAGULATION FACTOR XI) (HUMAN MONOCLONAL CLONE NVS250519 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL NVS250519 .LAMBDA.-CHAIN, DIMER
Common Name English
abelacimab [INN]
Common Name English
Code System Code Type Description
INN
10881
Created by admin on Tue Apr 01 23:16:47 GMT 2025 , Edited by admin on Tue Apr 01 23:16:47 GMT 2025
PRIMARY
CAS
2098724-83-3
Created by admin on Tue Apr 01 23:16:47 GMT 2025 , Edited by admin on Tue Apr 01 23:16:47 GMT 2025
PRIMARY
SMS_ID
100000183551
Created by admin on Tue Apr 01 23:16:47 GMT 2025 , Edited by admin on Tue Apr 01 23:16:47 GMT 2025
PRIMARY
FDA UNII
KX1N4TV7UY
Created by admin on Tue Apr 01 23:16:47 GMT 2025 , Edited by admin on Tue Apr 01 23:16:47 GMT 2025
PRIMARY
NCI_THESAURUS
C169755
Created by admin on Tue Apr 01 23:16:47 GMT 2025 , Edited by admin on Tue Apr 01 23:16:47 GMT 2025
PRIMARY
ACTIVE MOIETY
ABELACIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966